Safety and Efficacy of Erythropoietin in Traumatic Brain Injury Patients: A Pilot Randomized Trial

Background. Erythropoietin (EPO) is a neuroprotective agent utilized in stroke patients. This pilot study represents the first randomized trial of EPO in traumatic brain injury (TBI) patients. Methods. Adult, blunt trauma patients with evidence of TBI were randomized to EPO or placebo within 6 hours...

Descripción completa

Detalles Bibliográficos
Autores principales: Nirula, R., Diaz-Arrastia, R., Brasel, K., Weigelt, J. A., Waxman, K.
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2010
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2951080/
https://www.ncbi.nlm.nih.gov/pubmed/20948886
http://dx.doi.org/10.1155/2010/209848

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2951080/
https://www.ncbi.nlm.nih.gov/pubmed/20948886
http://dx.doi.org/10.1155/2010/209848

Ejemplares similares